DBDMEDIUM SIGNALFINANCIAL10-K

DBD shows solid operational improvement with operating income growing 33% alongside stronger cash position, while completing transition away from bankruptcy reorganization disclosure language.

The removal of fresh start accounting and bankruptcy emergence references suggests DBD has fully transitioned past its 2023 restructuring, now presenting itself as a stabilized operating entity. The meaningful improvement in operating performance combined with stronger cash reserves indicates the company's turnaround efforts are gaining traction.

Comparing 2026-02-12 vs 2025-02-25View on EDGAR →
FINANCIAL ANALYSIS

DBD delivered solid financial progress with operating income advancing 33% to $242 million, demonstrating meaningful operational improvements. The company strengthened its balance sheet with cash growing 25% to $369 million and stockholders equity expanding 18% to $1.1 billion. The overall picture suggests a company that has successfully navigated past its restructuring challenges and is now generating improved profitability with enhanced financial flexibility.

FINANCIAL STATEMENT CHANGES
Operating Income
P&L
+32.9%
$182.1M$242.0M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Cash & Equivalents
Balance Sheet
+24.5%
$296.2M$368.9M

Cash grew 24.5% — improving liquidity position supports investment and shareholder returns.

Stockholders Equity
Balance Sheet
+18.3%
$929.8M$1.1B

Equity base grew 18.3% — retained earnings accumulation or equity issuance strengthening the balance sheet.

LANGUAGE CHANGES
NEW — 2026-02-12
PRIOR — 2025-02-25
ADDED
The number of common shares outstanding as of January 30, 2026 was 35,173,038 .
This annual report on Form 10-K may contain statements that are not historical information and are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements give current expectations or forecasts of future events and are not guarantees of future performance.
These forward-looking statements include, but are not limited to, projections, statements regarding the Company's expected future performance (including expected results of operations), future financial condition, anticipated operating results, strategy plans, future liquidity and financial position.
Statements can generally be identified as forward looking because they include words such as "believes," "anticipates," "expects," "intends," "plans," "will," "estimates," "potential," "target," "predict," "project," "seek," and variations thereof or "could," "should" or words of similar meaning.
Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.
Except to the extent required by applicable law or regulation, the Company undertakes no obligation to update these forward-looking statements to reflect future events or circumstances or to reflect the occurrence of unanticipated events.
You should consider these factors carefully in evaluating forward-looking statements and are cautioned not to place undue reliance on such statements.
Diebold Nixdorf, Incorporated (collectively with its subsidiaries, the Company) automates, digitizes and transforms the way people bank and shop.
As a leading global technology and services partner to many of the world s top financial institutions and retailers, our integrated solutions connect digital and physical channels for consumers conveniently, securely and efficiently.
REMOVED
The number of common shares outstanding as of February 17, 2025 was 37,595,784 .
The Company is a global market leader in providing mission-critical hardware, software, and services to global blue-chip banking and retail clients.
As a partner to the majority of the world's top 100 financial institutions, top 10 global Fortune 500 petroleum companies and top 25 global retailers, the Company's integrated solutions connect digital and physical channels conveniently, securely and efficiently for millions of consumers each day.
Voluntary Reorganization and Fresh Start Accounting On August 11, 2023, we emerged from the Restructuring Proceedings described in Note 2 to the consolidated financial statements.
As discussed in Note 1 to the consolidated financial statements, upon emergence from the Proceedings, the Company qualified for and adopted fresh start accounting (Fresh Start Accounting), which resulted in the Company becoming a new entity for financial reporting purposes.
References to Predecessor relate to the consolidated statements of operations for the twelve months ended December 31, 2022 and for the period from January 1, 2023 through and including the adjustments from the application of Fresh Start Accounting on August 11, 2023 (Predecessor Periods).
References to Successor relate to the consolidated balance sheets of the reorganized Company as of December 31, 2023 and 2024 and the consolidated statements of operations for the period from August 12, 2023 through December 31, 2023 and for the twelve months ended December 31, 2024 (Successor Periods) and are not comparable to the consolidated financial statements of the Predecessor as indicated by the black line division in the financial statements and footnote tables, which emphasizes the lack of comparability between amounts presented.
For a more detailed discussion of the Restructuring Proceedings, see Note 2 to the consolidated financial statements.
The Company partners with other leading technology companies and regularly refines its research and development (R D) spend to support a better transaction experience for consumers.
Operational Priorities The Company is establishing foundational priorities to support its business for the current environment and beyond.
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →